NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissions.
Identifieur interne : 002E82 ( PubMed/Curation ); précédent : 002E81; suivant : 002E83NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissions.
Auteurs : Michael Schmidt [Allemagne] ; Veronika Brixner ; Brigitte Ruster ; Michael K. Hourfar ; Christian Drosten ; Wolfgang Preiser ; Erhard Seifried ; W Kurt RothSource :
- Transfusion [ 0041-1132 ] ; 2004.
Descripteurs français
- KwdFr :
- ARN viral (sang), Donneurs de sang, Dépistage systématique (), Humains, Réaction transfusionnelle, Sensibilité et spécificité, Syndrome respiratoire aigu sévère (), Syndrome respiratoire aigu sévère (diagnostic), Syndrome respiratoire aigu sévère (transmission), Techniques d'amplification d'acides nucléiques (normes), Trousses de réactifs pour diagnostic (normes), Virus du SRAS (génétique).
- MESH :
- diagnostic : Syndrome respiratoire aigu sévère.
- génétique : Virus du SRAS.
- normes : Techniques d'amplification d'acides nucléiques, Trousses de réactifs pour diagnostic.
- sang : ARN viral.
- Donneurs de sang, Dépistage systématique, Humains, Réaction transfusionnelle, Sensibilité et spécificité, Syndrome respiratoire aigu sévère.
English descriptors
- KwdEn :
- Blood Donors, Humans, Mass Screening (methods), Nucleic Acid Amplification Techniques (standards), RNA, Viral (blood), Reagent Kits, Diagnostic (standards), SARS Virus (genetics), Sensitivity and Specificity, Severe Acute Respiratory Syndrome (diagnosis), Severe Acute Respiratory Syndrome (prevention & control), Severe Acute Respiratory Syndrome (transmission), Transfusion Reaction.
- MESH :
- chemical , blood : RNA, Viral.
- diagnosis : Severe Acute Respiratory Syndrome.
- genetics : SARS Virus.
- methods : Mass Screening.
- prevention & control : Severe Acute Respiratory Syndrome.
- standards : Nucleic Acid Amplification Techniques, Reagent Kits, Diagnostic.
- transmission : Severe Acute Respiratory Syndrome.
- Blood Donors, Humans, Sensitivity and Specificity, Transfusion Reaction.
Abstract
The severe acute respiratory syndrome (SARS) was first described in February 2003. Close contact with symptomatic patients appears to be the main route of transmission, whereas blood transfusion transmission could not be ruled out.
DOI: 10.1111/j.1537-2995.2004.03269.x
PubMed: 15043560
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002E82
Links to Exploration step
pubmed:15043560Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissions.</title><author><name sortKey="Schmidt, Michael" sort="Schmidt, Michael" uniqKey="Schmidt M" first="Michael" last="Schmidt">Michael Schmidt</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Transfusion Medicine and Immunohematology, German Red Cross, Johan Wolfgang Goethe University, Frankfurt, Germany. mschmidt@bsdhessen.de</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Institute of Transfusion Medicine and Immunohematology, German Red Cross, Johan Wolfgang Goethe University, Frankfurt</wicri:regionArea></affiliation></author><author><name sortKey="Brixner, Veronika" sort="Brixner, Veronika" uniqKey="Brixner V" first="Veronika" last="Brixner">Veronika Brixner</name></author><author><name sortKey="Ruster, Brigitte" sort="Ruster, Brigitte" uniqKey="Ruster B" first="Brigitte" last="Ruster">Brigitte Ruster</name></author><author><name sortKey="Hourfar, Michael K" sort="Hourfar, Michael K" uniqKey="Hourfar M" first="Michael K" last="Hourfar">Michael K. Hourfar</name></author><author><name sortKey="Drosten, Christian" sort="Drosten, Christian" uniqKey="Drosten C" first="Christian" last="Drosten">Christian Drosten</name></author><author><name sortKey="Preiser, Wolfgang" sort="Preiser, Wolfgang" uniqKey="Preiser W" first="Wolfgang" last="Preiser">Wolfgang Preiser</name></author><author><name sortKey="Seifried, Erhard" sort="Seifried, Erhard" uniqKey="Seifried E" first="Erhard" last="Seifried">Erhard Seifried</name></author><author><name sortKey="Roth, W Kurt" sort="Roth, W Kurt" uniqKey="Roth W" first="W Kurt" last="Roth">W Kurt Roth</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:15043560</idno><idno type="pmid">15043560</idno><idno type="doi">10.1111/j.1537-2995.2004.03269.x</idno><idno type="wicri:Area/PubMed/Corpus">002E82</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002E82</idno><idno type="wicri:Area/PubMed/Curation">002E82</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002E82</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissions.</title><author><name sortKey="Schmidt, Michael" sort="Schmidt, Michael" uniqKey="Schmidt M" first="Michael" last="Schmidt">Michael Schmidt</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Transfusion Medicine and Immunohematology, German Red Cross, Johan Wolfgang Goethe University, Frankfurt, Germany. mschmidt@bsdhessen.de</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Institute of Transfusion Medicine and Immunohematology, German Red Cross, Johan Wolfgang Goethe University, Frankfurt</wicri:regionArea></affiliation></author><author><name sortKey="Brixner, Veronika" sort="Brixner, Veronika" uniqKey="Brixner V" first="Veronika" last="Brixner">Veronika Brixner</name></author><author><name sortKey="Ruster, Brigitte" sort="Ruster, Brigitte" uniqKey="Ruster B" first="Brigitte" last="Ruster">Brigitte Ruster</name></author><author><name sortKey="Hourfar, Michael K" sort="Hourfar, Michael K" uniqKey="Hourfar M" first="Michael K" last="Hourfar">Michael K. Hourfar</name></author><author><name sortKey="Drosten, Christian" sort="Drosten, Christian" uniqKey="Drosten C" first="Christian" last="Drosten">Christian Drosten</name></author><author><name sortKey="Preiser, Wolfgang" sort="Preiser, Wolfgang" uniqKey="Preiser W" first="Wolfgang" last="Preiser">Wolfgang Preiser</name></author><author><name sortKey="Seifried, Erhard" sort="Seifried, Erhard" uniqKey="Seifried E" first="Erhard" last="Seifried">Erhard Seifried</name></author><author><name sortKey="Roth, W Kurt" sort="Roth, W Kurt" uniqKey="Roth W" first="W Kurt" last="Roth">W Kurt Roth</name></author></analytic><series><title level="j">Transfusion</title><idno type="ISSN">0041-1132</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Blood Donors</term><term>Humans</term><term>Mass Screening (methods)</term><term>Nucleic Acid Amplification Techniques (standards)</term><term>RNA, Viral (blood)</term><term>Reagent Kits, Diagnostic (standards)</term><term>SARS Virus (genetics)</term><term>Sensitivity and Specificity</term><term>Severe Acute Respiratory Syndrome (diagnosis)</term><term>Severe Acute Respiratory Syndrome (prevention & control)</term><term>Severe Acute Respiratory Syndrome (transmission)</term><term>Transfusion Reaction</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>ARN viral (sang)</term><term>Donneurs de sang</term><term>Dépistage systématique ()</term><term>Humains</term><term>Réaction transfusionnelle</term><term>Sensibilité et spécificité</term><term>Syndrome respiratoire aigu sévère ()</term><term>Syndrome respiratoire aigu sévère (diagnostic)</term><term>Syndrome respiratoire aigu sévère (transmission)</term><term>Techniques d'amplification d'acides nucléiques (normes)</term><term>Trousses de réactifs pour diagnostic (normes)</term><term>Virus du SRAS (génétique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>RNA, Viral</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Mass Screening</term></keywords><keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Techniques d'amplification d'acides nucléiques</term><term>Trousses de réactifs pour diagnostic</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>ARN viral</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Nucleic Acid Amplification Techniques</term><term>Reagent Kits, Diagnostic</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Blood Donors</term><term>Humans</term><term>Sensitivity and Specificity</term><term>Transfusion Reaction</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Donneurs de sang</term><term>Dépistage systématique</term><term>Humains</term><term>Réaction transfusionnelle</term><term>Sensibilité et spécificité</term><term>Syndrome respiratoire aigu sévère</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The severe acute respiratory syndrome (SARS) was first described in February 2003. Close contact with symptomatic patients appears to be the main route of transmission, whereas blood transfusion transmission could not be ruled out.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15043560</PMID><DateCompleted><Year>2004</Year><Month>04</Month><Day>30</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0041-1132</ISSN><JournalIssue CitedMedium="Print"><Volume>44</Volume><Issue>4</Issue><PubDate><Year>2004</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Transfusion</Title><ISOAbbreviation>Transfusion</ISOAbbreviation></Journal><ArticleTitle>NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissions.</ArticleTitle><Pagination><MedlinePgn>470-5</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The severe acute respiratory syndrome (SARS) was first described in February 2003. Close contact with symptomatic patients appears to be the main route of transmission, whereas blood transfusion transmission could not be ruled out.</AbstractText><AbstractText Label="STUDY DESIGN AND METHODS" NlmCategory="METHODS">A SARS coronavirus (SARS-CoV) detection kit developed by C. Drosten (Bernhard Nocht Institute, BNI) was used to amplify SARS-CoV sequences from blood donor samples. We tested 31,151 blood donor samples in minipools of up to 96 samples. To validate the sensitivity of the assay, routine donor minipools (88 +/- 8 samples per pool) were spiked with plasma of an imported case of SARS or of a subsequently infected contact person, respectively. Gamma-irradiated cell culture supernatants of Vero E6 cells, infected with SARS-CoV, were used as positive controls.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">None of 31,151 blood donors were positive for the presence of SARS. Two 96-member plasma pools that were each spiked with 100 microL of plasma of the German index patient or his wife, respectively, were positive. Overall, 0.85 percent of test results had to be considered invalid owing to negative internal controls.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A real-time CoV PCR test is able to detect SARS-CoV in viremic blood donor samples even in the beginning of the disease when patients present minor clinical symptoms. Thus the assay could potentially help to prevent transfusion-associated SARS-CoV transmissions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Transfusion Medicine and Immunohematology, German Red Cross, Johan Wolfgang Goethe University, Frankfurt, Germany. mschmidt@bsdhessen.de</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brixner</LastName><ForeName>Veronika</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Ruster</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Hourfar</LastName><ForeName>Michael K</ForeName><Initials>MK</Initials></Author><Author ValidYN="Y"><LastName>Drosten</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Preiser</LastName><ForeName>Wolfgang</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Seifried</LastName><ForeName>Erhard</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Roth</LastName><ForeName>W Kurt</ForeName><Initials>WK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transfusion</MedlineTA><NlmUniqueID>0417360</NlmUniqueID><ISSNLinking>0041-1132</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011933">Reagent Kits, Diagnostic</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Transfusion. 2004 Apr;44(4):467-9</RefSource><PMID Version="1">15043559</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001782" MajorTopicYN="Y">Blood Donors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021141" MajorTopicYN="N">Nucleic Acid Amplification Techniques</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011933" MajorTopicYN="N">Reagent Kits, Diagnostic</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065227" MajorTopicYN="N">Transfusion Reaction</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>3</Month><Day>27</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>5</Month><Day>1</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>3</Month><Day>27</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15043560</ArticleId><ArticleId IdType="doi">10.1111/j.1537-2995.2004.03269.x</ArticleId><ArticleId IdType="pii">TRF03269</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002E82 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002E82 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:15043560
|texte= NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissions.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:15043560" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |